Regen BioPharma, Inc. is embarking on a development program to commercialize its modified mRNA anti-cancer vaccine targeting the Survivin protein. In the first phase...
Asymchem Laboratories ("Asymchem"), a leading CDMO serving the global pharmaceutical and biotech industry, announced its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical...
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates neutralization against the Omicron...
Angstrom Technology, a West Michigan cleanroom engineering company and portfolio company of ASGARD Partners & Co. announced its third acquisition in six months, the...
REGENXBIO Inc. announced additional positive interim data from the ongoing Phase II ALTITUDE™ trial of RGX-314 for the treatment of diabetic retinopathy (DR) without...
